⌘K

Login Start Free

Home/Filings/4/0001104659-20-112322

4//SEC Filing

Campagna Jason 4

Accession 0001104659-20-112322

CIK 0001270073other

View on SEC.gov Company Profile

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 7:02 PM ET

Size

4.9 KB

Accession

0001104659-20-112322

Insider Transaction Report

Form 4

Period: 2020-10-01

INTERCEPT PHARMACEUTICALS, INC.ICPT

Chief Medical Officer

Transactions

Tax Payment
Common Stock
2020-10-01$42.08/sh−112$4,713→ 8,597 total

Footnotes (1)

[F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock and restricted stock unit awards previously granted to the reporting person.

Documents

1 file

4
tm2032461d7_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

INTERCEPT PHARMACEUTICALS, INC.

CIK 0001270073

Entity typeother

Related Parties

1

filerCIK 0001793338

Filing Metadata

Form type: 4
Filed: Oct 4, 8:00 PM ET
Accepted: Oct 5, 7:02 PM ET
Size: 4.9 KB

View on SEC.gov